(RYN) Rayonier - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7549071030
Stock: Timberlands, Real Estate, Forest Products
Total Rating 31
Risk 66
Buy Signal -0.42
| Risk 5d forecast | |
|---|---|
| Volatility | 27.1% |
| Relative Tail Risk | -9.85% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.44 |
| Alpha | -17.77 |
| Character TTM | |
|---|---|
| Beta | 0.246 |
| Beta Downside | 0.225 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.28% |
| CAGR/Max DD | -0.18 |
EPS (Earnings per Share)
Revenue
Description: RYN Rayonier March 05, 2026
Rayonier Inc. (RYN) is a timberland real estate investment trust (REIT). The company owns or leases approximately 2.0 million acres of timberland in the U.S.
Timber REITs generate revenue primarily from timber sales and land management. These entities benefit from the biological growth of trees and often have favorable tax treatment.
Rayoniers holdings are concentrated in the U.S. South (1.72 million acres) and U.S. Pacific Northwest (307,000 acres), regions known for productive softwood timber. Timberland investments provide a natural resource-based asset with long-term growth potential.
For more detailed financial analysis and historical data, ValueRay offers comprehensive investor tools.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 474.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.35 > 1.0 |
| NWC/Revenue: 118.0% < 20% (prev 4.25%; Δ 113.7% < -1%) |
| CFO/TA 0.08 > 3% & CFO 256.7m > Net Income 474.4m |
| Net Debt (229.8m) to EBITDA (187.8m): 1.22 < 3 |
| Current Ratio: 3.11 > 1.5 & < 3 |
| Outstanding Shares: last quarter (162.2m) vs 12m ago 5.01% < -2% |
| Gross Margin: 32.46% > 18% (prev 0.40%; Δ 3206 % > 0.5%) |
| Asset Turnover: 14.09% > 50% (prev 32.66%; Δ -18.57% > 0%) |
| Interest Coverage Ratio: 3.82 > 6 (EBITDA TTM 187.8m / Interest Expense TTM 26.4m) |
Altman Z'' 3.58
| A: 0.17 (Total Current Assets 842.9m - Total Current Liabilities 271.3m) / Total Assets 3.40b |
| B: 0.08 (Retained Earnings 280.9m / Total Assets 3.40b) |
| C: 0.03 (EBIT TTM 101.0m / Avg Total Assets 3.44b) |
| D: 1.91 (Book Value of Equity 2.21b / Total Liabilities 1.15b) |
| Altman-Z'' Score: 3.58 = A |
Beneish M
| DSRI: none (Receivables none/40.2m, Revenue 484.5m/1.13b) |
| GMI: 1.23 (GM 32.46% / 39.77%) |
| AQI: 0.87 (AQ_t 0.74 / AQ_t-1 0.85) |
| SGI: 0.43 (Revenue 484.5m / 1.13b) |
| TATA: 0.06 (NI 474.4m - CFO 256.7m) / TA 3.40b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of RYN shares?
As of March 06, 2026, the stock is trading at USD 21.92 with a total of 2,513,141 shares traded.
Over the past week, the price has changed by +1.86%, over one month by -2.66%, over three months by +3.22% and over the past year by -11.07%.
Over the past week, the price has changed by +1.86%, over one month by -2.66%, over three months by +3.22% and over the past year by -11.07%.
Is RYN a buy, sell or hold?
Rayonier has received a consensus analysts rating of 3.57.
Therefor, it is recommend to hold RYN.
- StrongBuy: 1
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RYN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.8 | 22.4% |
| Analysts Target Price | 26.8 | 22.4% |
RYN Fundamental Data Overview March 02, 2026
P/E Trailing = 45.7234
P/E Forward = 47.8469
P/S = 13.4808
P/B = 2.9402
P/EG = 23.2357
Revenue TTM = 484.5m USD
EBIT TTM = 101.0m USD
EBITDA TTM = 187.8m USD
Long Term Debt = 845.3m USD (from longTermDebt, last quarter)
Short Term Debt = 200.0m USD (from shortTermDebt, last quarter)
Debt = 1.07b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 229.8m USD (from netDebt column, last quarter)
Enterprise Value = 6.76b USD (6.53b + Debt 1.07b - CCE 842.9m)
Interest Coverage Ratio = 3.82 (Ebit TTM 101.0m / Interest Expense TTM 26.4m)
EV/FCF = 32.71x (Enterprise Value 6.76b / FCF TTM 206.7m)
FCF Yield = 3.06% (FCF TTM 206.7m / Enterprise Value 6.76b)
FCF Margin = 42.66% (FCF TTM 206.7m / Revenue TTM 484.5m)
Net Margin = 97.92% (Net Income TTM 474.4m / Revenue TTM 484.5m)
Gross Margin = 32.46% ((Revenue TTM 484.5m - Cost of Revenue TTM 327.2m) / Revenue TTM)
Gross Margin QoQ = 41.96% (prev 32.90%)
Tobins Q-Ratio = 1.99 (Enterprise Value 6.76b / Total Assets 3.40b)
Interest Expense / Debt = 0.62% (Interest Expense 6.70m / Debt 1.07b)
Taxrate = 0.76% (200.0k / 26.4m)
NOPAT = 100.2m (EBIT 101.0m * (1 - 0.76%))
Current Ratio = 3.11 (Total Current Assets 842.9m / Total Current Liabilities 271.3m)
Debt / Equity = 0.49 (Debt 1.07b / totalStockholderEquity, last quarter 2.21b)
Debt / EBITDA = 1.22 (Net Debt 229.8m / EBITDA 187.8m)
Debt / FCF = 1.11 (Net Debt 229.8m / FCF TTM 206.7m)
Total Stockholder Equity = 2.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.79% (Net Income 474.4m / Total Assets 3.40b)
RoE = 21.80% (Net Income TTM 474.4m / Total Stockholder Equity 2.18b)
RoCE = 3.34% (EBIT 101.0m / Capital Employed (Equity 2.18b + L.T.Debt 845.3m))
RoIC = 3.12% (NOPAT 100.2m / Invested Capital 3.21b)
WACC = 6.46% (E(6.53b)/V(7.60b) * Re(7.42%) + D(1.07b)/V(7.60b) * Rd(0.62%) * (1-Tc(0.01)))
Discount Rate = 7.42% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 3.57%
[DCF] Terminal Value 77.80% ; FCFF base≈189.6m ; Y1≈124.4m ; Y5≈56.8m
[DCF] Fair Price = 4.34 (EV 1.54b - Net Debt 229.8m = Equity 1.31b / Shares 302.3m; r=6.46% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 34.02 | EPS CAGR: 0.0% | SUE: 0.10 | # QB: 0
Revenue Correlation: -34.11 | Revenue CAGR: -15.61% | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.10 | Chg7d=+0.010 | Chg30d=-0.005 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=0.41 | Chg7d=+0.019 | Chg30d=-0.073 | Revisions Net=-2 | Growth EPS=-27.6% | Growth Revenue=+203.8%
EPS next Year (2027-12-31): EPS=0.66 | Chg7d=+0.037 | Chg30d=+0.090 | Revisions Net=+0 | Growth EPS=+58.9% | Growth Revenue=+13.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.8% (Discount Rate 7.9% - Earnings Yield 2.2%)
[Growth] Growth Spread = +254.2% (Analyst 259.9% - Implied 5.8%)
P/E Forward = 47.8469
P/S = 13.4808
P/B = 2.9402
P/EG = 23.2357
Revenue TTM = 484.5m USD
EBIT TTM = 101.0m USD
EBITDA TTM = 187.8m USD
Long Term Debt = 845.3m USD (from longTermDebt, last quarter)
Short Term Debt = 200.0m USD (from shortTermDebt, last quarter)
Debt = 1.07b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 229.8m USD (from netDebt column, last quarter)
Enterprise Value = 6.76b USD (6.53b + Debt 1.07b - CCE 842.9m)
Interest Coverage Ratio = 3.82 (Ebit TTM 101.0m / Interest Expense TTM 26.4m)
EV/FCF = 32.71x (Enterprise Value 6.76b / FCF TTM 206.7m)
FCF Yield = 3.06% (FCF TTM 206.7m / Enterprise Value 6.76b)
FCF Margin = 42.66% (FCF TTM 206.7m / Revenue TTM 484.5m)
Net Margin = 97.92% (Net Income TTM 474.4m / Revenue TTM 484.5m)
Gross Margin = 32.46% ((Revenue TTM 484.5m - Cost of Revenue TTM 327.2m) / Revenue TTM)
Gross Margin QoQ = 41.96% (prev 32.90%)
Tobins Q-Ratio = 1.99 (Enterprise Value 6.76b / Total Assets 3.40b)
Interest Expense / Debt = 0.62% (Interest Expense 6.70m / Debt 1.07b)
Taxrate = 0.76% (200.0k / 26.4m)
NOPAT = 100.2m (EBIT 101.0m * (1 - 0.76%))
Current Ratio = 3.11 (Total Current Assets 842.9m / Total Current Liabilities 271.3m)
Debt / Equity = 0.49 (Debt 1.07b / totalStockholderEquity, last quarter 2.21b)
Debt / EBITDA = 1.22 (Net Debt 229.8m / EBITDA 187.8m)
Debt / FCF = 1.11 (Net Debt 229.8m / FCF TTM 206.7m)
Total Stockholder Equity = 2.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.79% (Net Income 474.4m / Total Assets 3.40b)
RoE = 21.80% (Net Income TTM 474.4m / Total Stockholder Equity 2.18b)
RoCE = 3.34% (EBIT 101.0m / Capital Employed (Equity 2.18b + L.T.Debt 845.3m))
RoIC = 3.12% (NOPAT 100.2m / Invested Capital 3.21b)
WACC = 6.46% (E(6.53b)/V(7.60b) * Re(7.42%) + D(1.07b)/V(7.60b) * Rd(0.62%) * (1-Tc(0.01)))
Discount Rate = 7.42% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 3.57%
[DCF] Terminal Value 77.80% ; FCFF base≈189.6m ; Y1≈124.4m ; Y5≈56.8m
[DCF] Fair Price = 4.34 (EV 1.54b - Net Debt 229.8m = Equity 1.31b / Shares 302.3m; r=6.46% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 34.02 | EPS CAGR: 0.0% | SUE: 0.10 | # QB: 0
Revenue Correlation: -34.11 | Revenue CAGR: -15.61% | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.10 | Chg7d=+0.010 | Chg30d=-0.005 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=0.41 | Chg7d=+0.019 | Chg30d=-0.073 | Revisions Net=-2 | Growth EPS=-27.6% | Growth Revenue=+203.8%
EPS next Year (2027-12-31): EPS=0.66 | Chg7d=+0.037 | Chg30d=+0.090 | Revisions Net=+0 | Growth EPS=+58.9% | Growth Revenue=+13.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.8% (Discount Rate 7.9% - Earnings Yield 2.2%)
[Growth] Growth Spread = +254.2% (Analyst 259.9% - Implied 5.8%)